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Abstract 
Background 
Pediatric liver transplant  (PLT) is a complex surgical procedure. Pediatric liver transplantation has 
evolved over the last two decades into an effective and widely accepted therapy for infants and 
children. We aimed to review the short and long term complications after oediatric liver 
transplantation.  
Materials and Methods  
The literature research was conducted in EMBASE, PubMed, Scopus, ISI Web of Science, Cochrane 
Library, and Google Scholar; were searched from January 1984 to January 2016. The following 
keywords were used: Liver transplantation, Pediatric Liver transplantation, Risk factors, 
Complication, and Mortality.  
Results  
The main complications after pediatric liver transplantation were: infections (51.4%) and surgical 
complications including (biliary complications [41.2%], and postoperative bleeding [27%]). In 
general, vascular complications were observed in 35% of studied children. 
Conclusion 
Infections and biliary complications were the most common outcome occurring in children after LT. 
Advances in post-transplant care and monitoring of the recipients, technical refinements enable the 
better results. 
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1- INTRODUCTION 
   The first human liver transplant was 
performed in 1963 by a surgical team led 
by Dr. Thomas Starzl of Denver, 
Colorado, United States. Dr. Starzl 
performed several additional transplants 
over a few years till the first short-term 
success was achieved in 1967 with one-
year survival post transplantation. Despite 
the development of viable surgical 
techniques, liver transplantation remained 
experimental through the 1970s, with one 
year patient survival in the vicinity of 
25%. The introduction of cyclosporin by 
Sir Roy Calne, Professor of Surgery 
Cambridge, markedly improved patient 
outcomes, and the 1980s was recognition 
of liver transplantation as a standard 
clinical treatment for both adult and 
pediatric patients with appropriate 
indications. Liver transplantation is now 
performed at over one hundred centers in 
the US, as well as numerous centers in 
Europe and elsewhere. One-year patient 
survival is 80–85%, and outcomes 
continue to improve, although liver 
transplantation remains a formidable 
procedure with frequent complications. 
The supply of liver allografts from non-
living donors is far short of the number of 
potential recipients, a reality that has 
spurred the development of living donor 
liver transplantation. The first altruistic 
living liver donation in Britain was 
performed in December 2012 at St James 
University Hospital Leeds (1-3).  
MATERIALS AND METHODS 
 2-1. Method 
     The following databases were searched 
for relevant papers and reports: Medline, 
Cinahl, Embase, Cochrane Collection, 
Pubmed, ISI Web of Knowledge, and 
Google Scholar. Key references from 
extracted papers were also hand-searched. 
These searches focused upon papers 
published between Jan 1984 and Jan 2016. 
Terms to evaluate the texts and websites, 
the singular or combination forms of the 
following keywords were used to search 
for the relevant literature: "Liver 
transplantation", "Risk factors", "Pediatric 
liver transplantation", "Complication", and 
"Mortality" and equivalent Persian words 
using bulletin index such as AND, OR. 
Included were: all Persian and English 
articles which have the mentioned 
keywords in the title and abstract and 
related to the purpose of the research, 
published between Jan 1984 to Jan 2016. 
Articles with incomplete data, and also 
from other languages were excluded. In 
the initial review, 301 articles were found 
Of the collected articles, 288 documents 
were excluded in several steps by 
processes of article selection. A total of 13 
studies were ultimately included in this 
review. The procedure of the search and 
selection of studies is appeared in 
Figure.1. 
 
Fig.1: Flowchart of selection of studies. 
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3- RESULTS 
     During the 32-yr period between Jan 
1984 and Jan 2016, we compared the 
complications of pediatric liver 
transplantation at different eras. Table.1 
(Please see the table at the end of paper), 
shows the general characteristics of the 
included studies. In terms of study sample 
size, three studies (27.07%) evaluated less 
than 100 patients and other studies 
(76.9%) assessed more than 100 patients. 
One study was a case control and others 
were retrospective review. Unfortunately, 
there are few studies with substantial 
numbers of patients that identify outcomes 
predictors. However the early recognition 
and correction of post-transplant 
complication improves graft and patient 
survival. The majority of complications 
and deaths occur within the first three 
months. Some of common complications 
after liver transplant include:  
3-1. Complications after liver 
transplant, collected from review of 
literatures (17)  
3-1-1. Bleeding 
Poor graft function, coagulopathy, 
imperfect hemostasis, or slippage of a tie 
can result in postoperative bleeding that 
requires re-exploration. Postoperative 
bleeding is reported in 8.5% of patients 
(9). Even if easily controlled, 
postoperative bleeding leads to increased 
cost, morbidity, and mortality. 
3-1-2. Biliary complications 
Biliary leak and stricture are the most 
common technical complications occurring 
in 22% to 47.3% of children (5, 12). 
Biliary drainage is re-established by bile 
duct to bile duct anastomosis, or more 
commonly hepaticojejunostomy.  
3-1-3. Rejection 
About  25% of patients develop at least 
one episode of acute rejection in the first 
weeks after liver transplantation (9, 14). A 
liver biopsy is required to confirm 
rejection. Acute rejection is characterized 
by the histological triad of endothelialitis, 
portal triad lymphocyte infiltration with 
bile duct injury, and hepatic parenchymal 
cell damage. 
3-1-4. Infections 
Immunosuppressive medications interfere 
with a patient's natural immunity; 
therefore, the patient will be more 
susceptible to infections after transplant 
surgery. Infections were the most common 
complications occurring in 28–51.4% of 
children (6, 9). Wound infection and 
superficial wound dehiscence occurred in 
(2.1%) and (28%) cases respectively. The 
most frequent source of infection was 
bacteremia (53%), lungs (24%), and 
abdomen (22%). The most frequent 
pathogens were bacteria (79%), candida 
(18%), and viruses (8%) (6). 
3-1-5. Liver failure 
Liver failure is a medical term meaning 
that the transplanted organ is not working 
properly. It's one of the most serious 
complications of a liver transplant 
and occurs in around one in 11.1% to 18% 
of children (11, 16). The most common 
cause is a disruption to the blood supply to 
the transplanted liver, caused by blood 
clots (thrombosis). Graft failure can 
develop suddenly, or slowly over a longer 
period of time. Symptoms can include 
jaundice, fluid retention (oedema), mental 
changes and a swollen abdomen. 
3-1-6. Vascular occlusions 
In general, vascular complications in 11.4 
to 35% of children who have had a liver 
transplant, was observed (9, 11).  
3-1-7. Hepatic artery thrombosis 
Thrombosis of the hepatic artery is the 
most common vascular occlusion, 
especially for living donor transplants, in 
which anastomosis is performed between 
smaller arteries. That is a major 
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complication, which often leads to graft 
loss. The incidence varies (1.03%–12%) 
depending on the type of graft, being less 
common in cut down livers (10, 12). 
Causes include poor surgical technique or 
kinking of the artery, endothelial injury 
(poor handling during retrieval or 
implantation), increased coagulability, or 
liver swelling during acute rejection. 
Factors such as high haematocrit and 
raised blood viscosity, arterial 
hypotension, infection, or perfusion injury 
predispose to thrombosis. Early 
recognition and immediate surgical 
revascularisation may salvage the graft.  
3-1-8. Portal vein thrombosis  
Portal vein thrombosis (PVT) occurs in 
approximately 3.2% to 9.8% of 
transplants, particularly in small children 
with hypoplastic portal veins (12, 15). Late 
portal vein complications present with 
signs of portal hypertension such as 
variceal haemorrhage or splenomegaly. 
The underlying cause may be technical, 
but on occasions remodelling of a “cut 
down” liver causes stretching of the portal 
vein.  
3-1-9. Renal Function 
CNIs, the principal immunosuppressive 
medications, used to prevent graft 
rejection, contribute to de novo acute and 
chronic posttransplant renal dysfunction. 
In children, the prevalence is not as well 
defined because serum creatinine is not a 
reliable measure of renal function and only 
a few studies have directly measured the 
glomerular filtration rate (GFR). Campbell 
et al. reported that renal dysfunction was 
present in 32% of children (13).  
3-1-10. Other complications include 
Incisional hernia and diaphragmatic hernia 
reported by others in 0.7% and 1.1%, 
respectively (4), while bowel obstruction 
and perforation were seen in 3.2% and 
2.5% of cases (4). The results of Berrocal 
et al. (12) showed that organ transplant 
recipients are at risk for PTLD. Arnon et 
al. (16) reported the metabolic disease and 
neonatal hepatitis occurred in (10.9%) and 
(7.5%) of cases, respectively. Wisniewski 
et al. (7) showed that 8.5% of children 
after LT were diagnosed with FA and/or 
EGID. Shroff et al. (8) reported food 
allergy symptoms in 6% of children after 
LT with confirmatory specific IgE testing 
in 4%. Atopic disease was present in 
(14.2%) of patients. Food allergy and 
atopic skin disease symptoms were present 
in 40% and 56% of cases, respectively. 
Asthma, allergic rhinitis, or both were 
found in 66% of cases. Varela et al. (14) 
reported posttransplant 
lymphoproliferative disorders in (5.7%) of 
children after LT.  
4- DISCUSSION 
4-1. Liver tranplatation 
     Liver transplant is a last resort 
treatment measure that can help save 
patient’s life when the liver no longer 
works. Also called a liver or hepatic 
transplantation, the treatment involves the 
surgical removal of the entire organ. It is 
then replaced with a healthy donor liver. 
Having a healthy liver is essential to 
longevity because the liver is responsible 
for nutrient distribution  and toxin removal 
in the body (18, 19). 
This preocedure is a treatment, used in 
appropriately selected patients, for acute 
and chronic liver failure due to any cause. 
It is not indicated if an acceptable 
alternative is available or if 
contraindications are present (eg, some 
cases of malignancy, terminal conditions, 
poor expected quality of outcome). 
Pediatric patients account for about 12.5% 
of liver transplant recipients. When a 
pediatric patient is likely to require a liver 
transplant, the medical management is 
generally divided into pretransplant and 
posttransplant periods, with the 
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posttransplant period further separated into 
early and late time frames. 
Medical treatment, surgery, and 
postsurgical care can be broken into 4 
basic steps: 
1. Candidate evaluation; 
2. Waiting period; 
3. Surgery; 
4. Postsurgical care (18). 
4-2. Indications 
Liver transplantation is potentially 
applicable to any acute or chronic 
condition resulting in irreversible liver 
dysfunction, provided that the recipient 
does not have other conditions that will 
preclude a successful transplant. 
Uncontrolled metastatic cancer outside 
liver, active drug or alcohol abuse and 
active septic infections are absolute 
contraindications. While HIV infection 
was once considered an absolute 
contraindication, this has been changing 
recently. Advanced age and serious heart, 
lung, or other disease may also prevent 
transplantation (relative contraindications). 
Most liver transplants are performed for 
chronic liver diseases that lead to 
irreversible scarring of the liver, or 
cirrhosis of the liver. Some centers use the 
Milan criteria to select patients with liver 
cancers for liver transplantation (20-22). 
4-3. Indications for pediatric liver 
transplantation 
About 50% of the pediatric patients who 
require a liver transplant have biliary 
atresia. Other disease states that progress 
to end-stage liver disease among pediatric 
patients and require liver transplantation 
include metabolic disorders and 
progressive intrahepatic cholestasis. 
Examples of metabolic derangements 
include Wilson disease, alpha 1-antitrypsin 
deficiency, tyrosinemia, and 
hemochromatosis. Other metabolic disease 
states leading to hepatic dysfunction 
include the following (23-25): 
 Crigler-Najjar syndrome; 
 Glycogenosis; 
 Hyperoxaluria; 
 Metabolic respiratory chain 
deficiencies; 
 Familial hypercholesterolemia 
 Methylmalonyl aciduria 
4-4. Techniques 
A liver transplant may involve the whole 
liver, a reduced liver, or a liver segment. 
Most transplants involve the whole organ 
but segmental transplants have been 
performed with increasing frequency in 
recent years. This would allow two liver 
recipients to be transplanted from one 
cadaveric donor or to allow for living 
donor liver donation. A reduced liver 
transplant may result if the donor liver is 
too large for the recipient (18, 26). 
Before transplantation, liver-support 
therapy might be indicated (bridging-to-
transplantation). Artificial liver support 
like liver dialysis or bio-artificial liver 
support concepts are currently under 
preclinical and clinical evaluation. 
Virtually all liver transplants are done in 
an orthotopic fashion, that is, the native 
liver is removed and the new liver is 
placed in the same anatomic location. The 
transplant operation can be conceptualized 
as consisting of the hepatectomy (liver 
removal) phase, the anhepatic (no liver) 
phase, and the post-implantation phase. 
The operation is done through a large 
incision in the upper abdomen. The 
hepatectomy involves division of all 
ligamentous attachments to the liver, as 
well as the common bile duct, hepatic 
artery, hepatic vein and portal vein. 
Usually, the retro-hepatic portion of the 
inferior vena cava is removed along with 
the liver, although an alternative technique 
preserves the recipient's vena cava 
("piggyback" technique) (27). The donor's 
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blood in the liver will be replaced by an 
ice-cold organ storage solution, such as 
University of Wisconsin solution (UW; 
Viaspan) or Histidine-tryptophan-
ketoglutarate, or Custodiol HTK until the 
allograft liver is implanted. Implantation 
involves anastomoses (connections) of the 
inferior vena cava, portal vein, and hepatic 
artery. After blood flow is restored to the 
new liver, the biliary (bile duct) 
anastomosis is constructed, either to the 
recipient's own bile duct or to the small 
intestine. The surgery usually takes 
between five and six hours, but may be 
longer or shorter due to the difficulty of 
the operation and the experience of the 
surgeon. The large majority of liver 
transplants use the entire liver from a non-
living donor for the transplant, particularly 
for adult recipients.  
A major advance in pediatric liver 
transplantation was the development of 
reduced size liver transplantation, in which 
a portion of an adult liver is used for an 
infant or small child. Further developments 
in this area included split liver 
transplantation, in which one liver is used 
for transplants for two recipients, and 
living donor liver transplantation, in which 
a portion of a healthy person's liver is 
removed and used as the allograft. Living 
donor liver transplantation for pediatric 
recipients involves removal of 
approximately 20% of the liver (Couinaud 
segments 2 and 3). Further advance in liver 
transplant involves only resection of the 
lobe of the liver involved in tumors and the 
tumor-free lobe remains within the 
recipient. This speeds up the recovery and 
the patient stay in the hospital quickly 
shortens to within 5–7 days. Many major 
medical centers are now using 
radiofrequency ablation of the liver tumor 
as a bridge while awaiting for liver 
transplantation. This technique has not 
been used universally and further 
investigation is warranted (28-30). 
4-5. Types of liver transplant  
There are three main ways a liver 
transplant can be carried out: 
 4-5-1. deceased organ donation: 
involves transplanting a liver that 
has been removed from a person 
who died recently.   
 4-5-2. living donor liver 
transplant: a section of liver is 
removed from a living donor; 
because the liver can regenerate 
itself, both the transplanted section 
and the remaining section of the 
donor's liver are able to regrow into 
a normal-sized liver. 
 4-5-3. split donation: a liver is 
removed from a person who died 
recently and is split into two 
pieces; each piece is transplanted 
into a different person, where they 
will grow to a normal size (23, 27).  
5- CONCLUSIONS 
    Liver transplantation is life saving for 
patients with end stage liver disease. Post 
liver transplantation complications may 
occour in all recipients. Patients should be 
followed by gastroenterologist for 
postoperative care, medications and tests. 
Parents are responsible to administer 
transplant medications to children up to 
age 18 to prevent liver transplant rejection. 
This is because teenage patients may stop 
taking the medications without mentioning 
it to their parents. Patients should be tested 
for allergies after liver 
transplantation,because of a higher chance 
in these group of patients. Acute and 
chronic liver failure, cirrhosis  of the liver, 
chronic active hepatitis, acute and chronic 
rejection may happen post liver 
transplantation. These could be eliminated 
and controlled by close patients 
observation, evaluations, and treatment. 
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   Table-1: Characteristics of included studies during (1984-2016) 
Author 
Country 
Year 
Reference 
Study design 
 
Inclusion criteria  Sample 
size 
 
Sample  
age 
Complication 
 
Ziaziaris, 
 Australia 
1986- 2014 
(4) 
Retrospective 
review 
All children who 
underwent LT 
242 Median age 
31-month 
General surgical complications were observed in 33 cases (11.7%).   
Wound infection 7(2.5%); Wound dehiscence 6 (2.1%); Incisional hernia 2(0.7%);  
Bowel perforation 9(3.2%); Bowel obstruction7(2.5%); Diaphragmatic hernia 
3(1.1%). 
Cortes, 
Spain 
1989-2013 
(5) 
Retrospective 
review 
All children who 
underwent LT and 
subsequently presented 
with a DH 
1032 <18 years 
 
 
 
The most common indications for LT in children in the overall series were: 
extrahepatic biliary atresia (EHBA; 488 or 47.3%), acute liver failure (ALF; 135 or 
13.1%), and cholestatic liver disease (66 or 6.4%). 
Kukreti,  
Canada 
1988-2011 
(6) 
Retrospective 
review 
All children who 
underwent LT 
145 Median age 
2.7 years 
Forty one patients (28%) had  infections. The most frequent source of infection was 
bacteremia (26/49, 53%),  lungs (12/49, 24%), and abdomen (11/49, 22%). The 
most frequent pathogens were bacteria (79%), candida (18%), and viruses (8%).  
Wisniewski, 
 USA  
1990- 2010 
(7) 
Retrospective 
review 
All children who 
underwent LT 
352 <18 years 
 
 
 
30 (8.5%) of children were diagnosed with FA and/or EGID. 
Shroff 
 USA 
1995-2010 
(8) 
Review and 
follow-up 
All children receiving 
chronic 
immunosuppression after 
orthotopic LT (OLT). 
 
176 
 
 
<18 years 
 
 
 
Reported food allergy symptoms in _6% of children after LT with confirmatory 
specific IgE testing in _4% . Atopic disease was present in 25 (14.2%) patients.  
Food allergy and atopic skin disease symptoms were present in 40%, and 56% of 
cases, respectively. Asthma, allergic rhinitis, or both were found in 66% of cases.  
Deng, 
China 
2006- 2009 
(9) 
Retrospective 
review 
All children received  LT 35 <14 years 
 
The most common postoperative complications were infections, 51.4% (18 cases),  
gastrointestinal bleeding, 8.5% (3 cases), and  vascular complications 11.4% (4 
cases). Rejection occurred in 25% of patients.  There was one perioperative death 
from primary graft non-function,2.8%.  The most common isolated bacteria of the 
pathogen spectrum were Staphylococcus epidermidis. 
Jones 
Australia. 
1986- 2007 
(10) 
Retrospective 
review 
All children who 
underwent LT 
194 <18 years 
 
Two of 194 (1.03%) patients developed mycotic aneurysms of the hepatic artery. 
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Farmer, 
USA 
1984- 2006  
(11) 
Retrospective 
review 
All children who 
underwent PLTx 
657 <18 years 
 
The most common causes of patient death were sepsis (28%), multisystem organ 
failure (16%), and  liver failure (18%) and  vascular complications (35%). 
 
Berrocal, 
Spain 
1989-2004 
(12) 
Retrospective 
review 
All children who 
underwent LT 
321 Age range, 
6-204 
months 
Portal vein thrombosis (3.2%). Hepatic Artery Stenosis (12%). Vascular 
complications (35%). Portal Vein Stenosis (4%). IVC Thrombosis in less than (1%). 
Biliary complications (27%). Organ transplant recipients are at risk for PTLD(3%). 
Campbell,  
USA. 
1986- 1999 
(13) 
Case-control 
study 
All children who 
received a primary LT 
and who survived for at 
least 3 years after 
transplant. 
 
117 
 
 
Age range, 
3-14.6 years 
 Renal dysfunction was present in 32%. 
Varela,  
Mexico. 
1998-2004 
(14) 
Retrospective 
review 
All children who 
received an OLT 
35 Age range 
0.7- 17.2 
years 
Biliary complications )22%).  Posttransplant cytomegalovirus infection or 
reactivation (28%), acute rejection (25%), posttransplant lymphoproliferative 
disorders (5.7%). 
Tiao, 
USA. 
1986-2003 
(15) 
Retrospective 
review 
All children who 
received an OLT 
81 <1 year Hepatic artery thrombosis: 6.2% and Portal vein thrombosis: 9.8%. 
Arnon,  
USA. 
1987-2008 
(16) 
Retrospective 
review 
The Infants  ≤5 kg who 
had LT  
570 <5 year Biliary atresia (41.2%); Acute liver failure (11.1%); Metabolic disease (10.9%);  
Neonatal hepatitis (7.5%); TPN(6.5%). 
  FA: Food allergy; EGID: Eosinophilic gastrointestinal disorders; TPN: Total parenteral nutrition. 
 
 
 
 
 
